Wegman Toby

Director, 10% owner at BIOSPECIFICS TECHNOLOGIES CORP

Sold, on record
$20.1M
Dollars the filings state
Form 4 sales
24
Latest Sep 10, 2019
Form 144 notices
0
Proposed sales
Companies
1
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Timeline

  1. 1 Form 4 sale BIOSPECIFICS TECHNOLOGIES CORPPlan not stated
    Aug 30, 2016 2016

    Sold 4,299 shares at $37.54 ($161k)

    Wegman Toby, President

    Sold 0.4% of holdings ($36.8M position)975,879 shares left0.4x usual sizeFiling

  2. 2 Form 4 sale BIOSPECIFICS TECHNOLOGIES CORPPlan not stated
    Sep 2, 2016 +3 days

    Sold 9,201 shares at $37.53 ($345k)

    Wegman Toby, President

    Sold 0.9% of holdings ($36.6M position)966,678 shares left1.1x usual sizeFiling

  3. 3 Form 4 sale BIOSPECIFICS TECHNOLOGIES CORPPlan not stated
    Sep 13, 2016 +11 days

    Sold 3,605 shares at $37.55 ($135k)

    Wegman Toby, Director

    Sold 0.4% of holdings ($36.3M position)963,073 shares left0.4x usual sizeFiling

  4. 4 Form 4 sale BIOSPECIFICS TECHNOLOGIES CORPPlan not stated
    Sep 15, 2016 +2 days

    Sold 3,100 shares at $41.21 ($128k)

    Wegman Toby, Director

    Sold 0.3% of holdings ($39.7M position)959,973 shares left0.5x usual sizeFiling

  5. 5 Form 4 sale BIOSPECIFICS TECHNOLOGIES CORPPlan not stated
    Nov 29, 2016 +75 days

    Sold 10,000 shares at $48.08 ($481k)

    Wegman Toby, Director

    Sold 1% of holdings ($46.2M position)949,973 shares left2.5x usual sizeFiling

  6. 6 Form 4 sale BIOSPECIFICS TECHNOLOGIES CORPPlan not stated
    Aug 17, 2018 +626 days

    Sold 2,500 shares at $51.89 ($130k)

    Wegman Toby, Director, 10% owner

    Sold 0.3% of holdings ($49.3M position)947,473 shares left0.6x usual sizeFiling

  7. 7 Form 4 sale BIOSPECIFICS TECHNOLOGIES CORPPlan not stated
    May 21, 2019 +277 days

    Sold 5,500 shares at $64.06 ($352k)

    Wegman Toby, Director, 10% owner

    Sold 0.6% of holdings ($60.9M position)945,073 shares leftFiling

  8. 8 Form 4 sale BIOSPECIFICS TECHNOLOGIES CORPPlan not stated
    Sep 10, 2019 +112 days

    Sold 10,000 shares at $55.17 ($552k)

    Wegman Toby, Director, 10% owner

    Sold 1.1% of holdings ($52.1M position)935,073 shares leftFiling

Every transaction

Loading transactions…

Sales and notices (24)

Form 144 notices and Form 4 sales by Wegman Toby
Source
Sep 10, 2019Sep 10, 2019BIOSPECIFICS TECHNOLOGIES CORPDirector, 10% ownerForm 4 sale10,000$552k1.1%Plan not statedSEC
May 21, 2019May 22, 2019BIOSPECIFICS TECHNOLOGIES CORPDirector, 10% ownerForm 4 sale5,500$352k0.6%Plan not statedSEC
Aug 17, 2018Aug 17, 2018BIOSPECIFICS TECHNOLOGIES CORPDirector, 10% ownerForm 4 sale2,500$130k0.3%Plan not statedSEC
Nov 29, 2016Nov 29, 2016BIOSPECIFICS TECHNOLOGIES CORPDirectorForm 4 sale10,000$481k1.0%Plan not statedSEC
Sep 15, 2016Sep 16, 2016BIOSPECIFICS TECHNOLOGIES CORPDirectorForm 4 sale3,100$128k0.3%Plan not statedSEC
Sep 13, 2016Sep 13, 2016BIOSPECIFICS TECHNOLOGIES CORPDirectorForm 4 sale3,605$135k0.4%Plan not statedSEC
Sep 2, 2016Sep 2, 2016BIOSPECIFICS TECHNOLOGIES CORPPresidentForm 4 sale9,201$345k0.9%Plan not statedSEC
Aug 30, 2016Aug 30, 2016BIOSPECIFICS TECHNOLOGIES CORPPresidentForm 4 sale4,299$161k0.4%Plan not statedSEC
May 18, 2016May 19, 2016BIOSPECIFICS TECHNOLOGIES CORPDirectorForm 4 sale25,000$825k2.5%Plan not statedSEC
Dec 2, 2014Dec 4, 2014BIOSPECIFICS TECHNOLOGIES CORPDirectorForm 4 sale2,950$116k63.3%UnusualSEC
Nov 24, 2014Nov 25, 2014BIOSPECIFICS TECHNOLOGIES CORPDirectorForm 4 sale12,050$471k72.1%UnusualSEC
Jun 15, 2012Jun 18, 2012BIOSPECIFICS TECHNOLOGIES CORPDirector, 10% ownerForm 4 sale6,339$116k78.7%UnusualSEC
Jun 11, 2012Jun 13, 2012BIOSPECIFICS TECHNOLOGIES CORPDirector, 10% ownerForm 4 sale1,500$27k15.7%Plan not statedSEC
Jun 6, 2012Jun 8, 2012BIOSPECIFICS TECHNOLOGIES CORPDirector, 10% ownerForm 4 sale101$2k1.0%Plan not statedSEC
Jun 4, 2012Jun 5, 2012BIOSPECIFICS TECHNOLOGIES CORPDirector, 10% ownerForm 4 sale2,500$43k20.6%Plan not statedSEC
May 30, 2012May 31, 2012BIOSPECIFICS TECHNOLOGIES CORPDirector, 10% ownerForm 4 sale121$2k1.0%Plan not statedSEC
May 22, 2012May 24, 2012BIOSPECIFICS TECHNOLOGIES CORPDirector, 10% ownerForm 4 sale1,000$16k7.5%Plan not statedSEC
May 17, 2012May 18, 2012BIOSPECIFICS TECHNOLOGIES CORPDirector, 10% ownerForm 4 sale1,725$28k11.5%Plan not statedSEC
Sep 13, 2010Sep 15, 2010BIOSPECIFICS TECHNOLOGIES CORPDirector, 10% ownerForm 4 sale150,000$3.5M13.0%Plan not statedSEC
Nov 27, 2009Dec 1, 2009BIOSPECIFICS TECHNOLOGIES CORPDirector, 10% ownerForm 4 sale100,000$3M8.0%Plan not statedSEC
Sep 15, 2009Sep 17, 2009BIOSPECIFICS TECHNOLOGIES CORPDirector, 10% ownerForm 4 sale100,000$2.4M7.4%Plan not statedSEC
Feb 5, 2009Feb 11, 2009BIOSPECIFICS TECHNOLOGIES CORPDirector, 10% ownerForm 4 sale45,000$900k3.2%Plan not statedSEC
Apr 7, 2008Apr 9, 2008BIOSPECIFICS TECHNOLOGIES CORPDirector, 10% ownerForm 4 sale200,000$2.2M14.0%Plan not statedSEC
Feb 1, 2008Feb 5, 2008BIOSPECIFICS TECHNOLOGIES CORPDirector, 10% ownerForm 4 sale344,114$4.1M21.9%Plan not statedSEC